Gilead Sciences Q2 2016 Earnings Results

Loading viewer...

earnings

Format: PDF earnings

Gilead Sciences presents Q2 2016 earnings results with financial commentary from executive leadership including CEO John Milligan and CFO Robin Washington. The presentation covers antiviral programs, HCV treatment products, and pipeline candidates including oncology and inflammation programs.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Gilead Sciences

View all →

Gilead Sciences 2017 J.P. Morgan Healthcare Conference

conference

33 Pages

Gilead Sciences Q3 2022 Financial Results

earnings

Similar earningss from other companies

Browse all →

Inogen Q1 2023 Supplemental Financial Information

earnings

9 Pages

Inogen, Inc.

Merck Q1 2023 Earnings Results | Global Diversification

earnings